ArticleNature communications2022

Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.

Sruthi Ravindranathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.